These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4860064)

  • 21. Chorioallantoic membrane measles: development and clinical evaluation of a new further attenuated measles vaccine.
    Cerini CP; Arguedas J; Hernandez G; Frickey P; Douglas AV
    Appl Microbiol; 1974 Apr; 27(4):763-6. PubMed ID: 4856949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunological survey of measles--Czechoslavakian Republic, 1970].
    Sejda J; Strauss J; Helcl J; Jelínek J
    Cesk Epidemiol Mikrobiol Imunol; 1972 Jan; 21(1):26-33. PubMed ID: 4258673
    [No Abstract]   [Full Text] [Related]  

  • 25. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 26. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A field trial of further attenuated live measles virus vaccines in Japan, 1968.
    Jpn J Med Sci Biol; 1969 Aug; 22(4):191-200. PubMed ID: 4982563
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 30. A field with a liver measles-mumps-rubella vaccine.
    Walters VW; Miller SA; Jackson JE; Kenny MT
    Clin Pediatr (Phila); 1975 Oct; 14(10):928-33. PubMed ID: 1100294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 32. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum titration of children vaccinated against measles].
    Morzycka M; Barteczkoi
    Pediatr Pol; 1968 Jul; 43(7):813-6. PubMed ID: 4174897
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles vaccination.
    Kukla LF
    Compr Ther; 1977 Jun; 3(6):41-6. PubMed ID: 68846
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of a new live measles vaccine derived in chick chorioallantoic membranes.
    Halsey NA; Weiner LB; Meyers MG; Herrmann KL; Hinman A
    J Biol Stand; 1981 Oct; 9(4):507-11. PubMed ID: 7033226
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative trial of further attenuated measles vaccines.
    Hendrickse RG; Montefiore D; Sherman P; Peradze T
    Br Med J; 1966 Mar; 1(5490):779-81. PubMed ID: 5910109
    [No Abstract]   [Full Text] [Related]  

  • 37. [On vaccination against measles with live and attenuated virus (Schwarz strain)].
    Monaci V; Imperato C; Battistini A; Nardi G; Grzincich GL; Bellelli E; Mazzeo G
    Ann Sclavo; 1973; 15(3):134-40. PubMed ID: 4776383
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.
    Low N; Kraemer S; Schneider M; Restrepo AM
    Vaccine; 2008 Jan; 26(3):383-98. PubMed ID: 18082295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles].
    Domorázková E; Janotová J; Vodicková M; Drevo M
    Cesk Pediatr; 1975 Oct; 30(10):468-70. PubMed ID: 1212713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.